Brief: Bionano Genomics Announces Study Demonstrating Utility Of OGM For Quality Evaluation Of Human Induced Pluripotent Stem Cells (IPSCS)
08/09/2022 13:03
Sept 8 (Reuters) - Bionano Genomics Inc BNGO.O :
* BIONANO GENOMICS ANNOUNCES PUBLICATION OF STUDY
DEMONSTRATING
UTILITY OF OGM AS PART OF A COMPREHENSIVE WORKFLOW FOR QUALITY
EVALUATION OF HUMAN INDUCED PLURIPOTENT STEM CELLS (IPSCS)
Source text for Eikon: ID:nGNX7h75cx
Further company coverage: BNGO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bionano Genomics
See all newsBionano Genomics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Bionano Genomics Q2 revenue rises on increased clinical adoption
Brief: Bionano Genomics Q2 Revenue USD 8.2 Million
Bionano Genomics, Inc. expected to post a loss of 68 cents a share - Earnings Preview
Bionano Genomics Q1 revenue up 4%, margin improves; to retire convertible debt